Literature DB >> 17383311

Publication or presentation of results from multicenter clinical trials: evidence from an academic medical center.

Aslan T Turer1, Kenneth W Mahaffey, Kate L Compton, Robert M Califf, Kevin A Schulman.   

Abstract

BACKGROUND: Nonpublication of research results threatens the integrity of clinical research, but the extent of nonpublication and factors associated with publication remain poorly documented. We sought to examine rates of publication or presentation of research findings from multicenter clinical trials and determine what factors are associated with dissemination of results.
METHODS: We conducted a follow-up study of 217 prospective, multicenter clinical trials of treatment approved in 1998 by the institutional review board of a large academic medical center, of which 197 had enrolled participants and were not known to be ongoing. Follow-up included searches of the literature and the Internet and telephone and e-mail inquiries to investigators and research sponsors. The main outcome measures were manuscript publication or other presentation of research results.
RESULTS: Results of 110 (56%) out of 197 multicenter clinical trials have been published in the peer-reviewed literature. Results of 87 (44%) studies have not been published, and results of 52 (26%) studies have not been disseminated in any form. The rate of dissemination of trial results was highest for studies that were phase 3 (81%), lowest risk (86%), and investigational (76%). The dissemination rate was lowest for studies that were supported by internal funds (50%). However, none of these associations were statistically significant.
CONCLUSIONS: Results of almost half of the multicenter clinical trials conducted in part at a large academic medical center have never been published. Mechanisms to ensure public dissemination of clinical trial results are needed.

Entities:  

Mesh:

Year:  2007        PMID: 17383311     DOI: 10.1016/j.ahj.2007.01.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  Are results from pharmaceutical-company-sponsored studies available to the public?

Authors:  Rafael Dal-Ré; Alejandro Pedromingo; Manuel García-Losa; Juan Lahuerta; Rafael Ortega
Journal:  Eur J Clin Pharmacol       Date:  2010-09-16       Impact factor: 2.953

2.  What is the ultimate fate of presented abstracts? The conversion rates of presentations to publications over a five-year period from three North American plastic surgery meetings.

Authors:  Tournesol N Gregory; Tianyi Liu; Andrew Machuk; Jugpal S Arneja
Journal:  Can J Plast Surg       Date:  2012

3.  Can UK NHS research ethics committees effectively monitor publication and outcome reporting bias?

Authors:  Rasheda Begum; Simon Kolstoe
Journal:  BMC Med Ethics       Date:  2015-07-25       Impact factor: 2.652

4.  Extent of non-publication in cohorts of studies approved by research ethics committees or included in trial registries.

Authors:  Christine Schmucker; Lisa K Schell; Susan Portalupi; Patrick Oeller; Laura Cabrera; Dirk Bassler; Guido Schwarzer; Roberta W Scherer; Gerd Antes; Erik von Elm; Joerg J Meerpohl
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

5.  Do medical interns publish findings of compulsory audit or research projects? Five-year experience from a single centre in New Zealand.

Authors:  Yassar Alamri; Khalid Alsahli; Jenny Butler; Tom Cawood
Journal:  J Adv Med Educ Prof       Date:  2020-04

Review 6.  Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review.

Authors:  Kerry Dwan; Carrol Gamble; Paula R Williamson; Jamie J Kirkham
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.